Cadence Design Systems Raises 2026 Revenue Outlook to 21% Growth on $1.63 Billion Quarter
Cadence also authorized an additional $2.5 billion in share repurchases and reported a record backlog of $8.2 billion.
News
Verizon Reports Third-Quarter Revenue of $34.3 Billion, Up 1.5%
Verizon raised its full-year 2026 guidance for the third consecutive quarter, lifting Adjusted EPS to $5.04 to $5.06.
RRC
Range Resources Stock Jumps 17.7% on Agreement to Be Acquired by EQT in All-Stock Deal
Range holders would receive 0.987 EQT shares for each Range share, with Range stockholders owning about 27% of the combined company.
ORKA
Oruka Stock Jumps 12.7% on Positive Week 16 Psoriasis Trial Data for ORKA-001
The 61% PASI 100 response in the high-dose group matched results from the earlier EVERLAST-A trial, and the company plans Phase 3 trials in the first half of 2027.
CLYM
Climb Bio Stock Falls 13.5% on the Day It Reported Early Kidney Drug Data
The filing, accepted before the open Monday, reported initial Phase 2 results for budoprutug in primary membranous nephropathy, and no source ties the decline to a specific item in it.
AVBP
ArriVent Shares Fall 27% on Monday, the Day Early ARR-217 Trial Data Were Filed
Neither the filing nor the press release attached to it says why the stock dropped, though the company called the early response rates encouraging.